Search
Apellis Pharmaceuticals Inc
APLSAdd to Watchlist
41.030USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
5.25BMarket Cap
38.75P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-05-13The current earnings forecast score of Apellis Pharmaceuticals Inc is 6.48, ranking 132 out of 156 in the Pharmaceuticals industry. The average price target is 36.00, with a high of 55.00 and a low of 19.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Apellis Pharmaceuticals Inc's price target?
Analysts forecast that Apellis Pharmaceuticals Inc's price target is USD 36.00, with the highest forecast at USD 55.00 and the lowest forecast at USD 19.00.
How have Apellis Pharmaceuticals IncAPLS's recent earnings per share performed?
The market expectation was USD 0.15, while Apellis Pharmaceuticals IncAPLS's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.33.
